Your browser doesn't support javascript.
loading
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.
Brockwell, Natasha K; Rautela, Jai; Owen, Katie L; Gearing, Linden J; Deb, Siddhartha; Harvey, Kate; Spurling, Alex; Zanker, Damien; Chan, Chia-Ling; Cumming, Helen E; Deng, Niantao; Zakhour, Jasmine M; Duivenvoorden, Hendrika M; Robinson, Tina; Harris, Marion; White, Michelle; Fox, Jane; Ooi, Corinne; Kumar, Beena; Thomson, Jacqui; Potasz, Nicole; Swarbrick, Alex; Hertzog, Paul J; Molloy, Tim J; Toole, Sandra O'; Ganju, Vinod; Parker, Belinda S.
Affiliation
  • Brockwell NK; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.
  • Rautela J; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Owen KL; 3Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Gearing LJ; 4The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC Australia.
  • Deb S; 5Department of Medical Biology, University of Melbourne, Melbourne, VIC Australia.
  • Harvey K; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.
  • Spurling A; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Zanker D; 3Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Chan CL; 6Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC Australia.
  • Cumming HE; 7Department of Molecular and Translational Science, Monash University, Clayton, VIC Australia.
  • Deng N; Anatpath, Gardenvale, VIC Australia.
  • Zakhour JM; Cancer Research Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Sydney, NSW Australia.
  • Duivenvoorden HM; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.
  • Robinson T; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Harris M; 3Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • White M; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.
  • Fox J; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Ooi C; 3Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Kumar B; Cancer Research Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Sydney, NSW Australia.
  • Thomson J; 6Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC Australia.
  • Potasz N; 7Department of Molecular and Translational Science, Monash University, Clayton, VIC Australia.
  • Swarbrick A; Cancer Research Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Sydney, NSW Australia.
  • Hertzog PJ; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.
  • Molloy TJ; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.
  • Toole SO; 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC Australia.
  • Ganju V; 10Monash Health, Clayton, VIC Australia.
  • Parker BS; 10Monash Health, Clayton, VIC Australia.
NPJ Precis Oncol ; 3: 21, 2019.
Article in En | MEDLINE | ID: mdl-31482136

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Precis Oncol Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Precis Oncol Year: 2019 Type: Article